ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 100 filers reported holding ANTARES PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $399,000 | +55.9% | 84,997 | +11.5% | 0.00% | +50.0% |
| Q3 2019 | $256,000 | +13.3% | 76,248 | +11.3% | 0.00% | 0.0% |
| Q2 2019 | $226,000 | +53.7% | 68,498 | +41.2% | 0.00% | +100.0% |
| Q1 2019 | $147,000 | +20.5% | 48,498 | +7.8% | 0.00% | 0.0% |
| Q4 2018 | $122,000 | -60.3% | 44,987 | -50.8% | 0.00% | -66.7% |
| Q3 2018 | $307,000 | +37.7% | 91,487 | +6.0% | 0.00% | 0.0% |
| Q2 2018 | $223,000 | +6.7% | 86,337 | -9.0% | 0.00% | 0.0% |
| Q1 2018 | $209,000 | +3.0% | 94,837 | -6.9% | 0.00% | 0.0% |
| Q4 2017 | $203,000 | +10050.0% | 101,837 | +20267.4% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |